M&A TRANSACTION · 2020
Livongo Health, Inc. acquired by Teladoc Health, Inc.
$13.84B· 155.5x EBITDA· 23.10x revenue
Target
Livongo Health, Inc.
United States and Canada
Livongo Health, Inc. provides an integrated suite of solutions for the healthcare industry in North America. The company offers solutions in the field of diabetes, diabetes prevention, high blood pressure, and weight management. The company provides a connected blood glucose meter, weighing scale, and blood pressure meter. Its platform offers automatic data uploading; real-time insights and feedback on patient’s readings; access to expert coaches; and more. The company was formerly known as EosH
Acquirer
Teladoc Health, Inc.
Strategic buyer
Disclosed financials at time of acquisition
Revenue
$598.0M
EBITDA
$89.0M
Deal Value
$13.84B
EV/EBITDA
155.5x
Context
This $13.84B acquisition of Livongo Health, Inc. by Teladoc Health, Inc. sits in the healthtech sub-vertical. The 155.5x EBITDA multiple paid in 2020 can be compared against the population median for healthtech transactions of similar size on our Healthtech valuation hub. Teladoc Health, Inc. is acquiring as a strategic buyer; see how strategic acquirers typically price healthtech businesses on our Healthtech strategic buyer-pool page.
Source
Data sourced from SEC Fairness Opinion — primary source. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology
Value your own healthtech
Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.
Compare your business to the Livongo Health, Inc. acquisition.